EFFECT OF THE SELECTIVE ESTROGEN-RECEPTOR MODULATOR RALOXIFENE ON EXPLANTED UTERINE GROWTH IN RATS

被引:15
|
作者
SWISHER, DK [1 ]
TAGUE, RM [1 ]
SEYLER, DE [1 ]
机构
[1] ELI LILLY & CO,INDIANAPOLIS,IN 46285
关键词
ENDOMETRIOSIS; ESTROGEN ANTAGONIST; RAT; MODEL;
D O I
10.1002/ddr.430360107
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Raloxifene is a selective estrogen receptor modulator known to have antiestrogenic effects on uterine tissue. In this study, the effects of raloxifene on uterine explant growth were evaluated in rats. Rats were ovariectomized, implanted with an estradiol pellet, and an endometriosis-like state was artificially created by suturing uterine explants near mesenteric blood vessels. Approximately 21 days after explant surgery, rats with confirmed uterine explant growth were given raloxifene orally at doses of 0 or 10 mg/kg/day for 7 or 14 days. After 7 days of raloxifene treatment, explant weight and volume were significantly decreased. Fourteen days of raloxifene treatment, also caused a decrease in explant weight and volume, though not statistically significant. In addition, raloxifene treatment caused weight of the remaining uterine horn to decrease. Histological examination of the explants confirmed the presence of endometrial tissue similar to that seen in the uterus. In this study, raloxifene suppressed explanted uterine growth in a rat model designed to mimic human endometriosis. (C) 1995 Wiley-Liss, Inc.
引用
下载
收藏
页码:43 / 45
页数:3
相关论文
共 50 条
  • [22] Mechanism of Action and Preclinical Profile of Raloxifene, a Selective Estrogen Receptor Modulator
    Bryant H.U.
    Walls E.L.
    Reviews in Endocrine and Metabolic Disorders, 2001, 2 (1) : 129 - 138
  • [23] Chemoprevention of colon cancer by raloxifene, a selective estrogen receptor modulator (SERM).
    Rao, Chinthalapally V.
    Janakiram, Naveena B.
    Swamy, Malisetty V.
    Guruswamy, Suresh
    Patlolla, Jagan M. R.
    Thungathurthi, Ruchita
    Kopelovich, Levy
    Steele, Vernon E.
    CANCER RESEARCH, 2006, 66 (08)
  • [24] Inhibition of intimal hyperplasia using the selective estrogen receptor modulator raloxifene
    Selzman, CH
    Turner, AS
    Gaynor, JS
    Miller, SA
    Monnet, E
    Harken, AH
    ARCHIVES OF SURGERY, 2002, 137 (03) : 333 - 336
  • [25] Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women
    Blum, A
    Schenke, WH
    Hathaway, L
    Mincemoyer, R
    Csako, G
    Waclawiw, MA
    Cannon, RO
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (08): : 892 - +
  • [26] Effect of raloxifene (a Selective Estrogen Receptor Modulator (SERM)) as coadjuvant to antidepressant treatment: A case report
    Usall, Judith
    Coromina, Marta
    Araya, Susana
    Ochoa, Susana
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2011, 39 (05): : 334 - 335
  • [27] Effect of Selective Estrogen Receptor Modulator/Raloxifene Analogue on Proliferation and Collagen Metabolism of Tendon Fibroblast
    Irie, Toru
    Takahata, Masahiko
    Majima, Tokifumi
    Abe, Yuichiro
    Komatsu, Miki
    Iwasaki, Norimasa
    Minami, Akio
    CONNECTIVE TISSUE RESEARCH, 2010, 51 (03) : 179 - 187
  • [28] Cardioprotective Effect of Selective Estrogen Receptor Modulator Raloxifene Are Mediated by Heme Oxygenase in Estrogen-Deficient Rat
    Posa, Aniko
    Szabo, Renata
    Kupai, Krisztina
    Berko, Aniko Magyarine
    Veszelka, Medea
    Szucs, Gergo
    Borzsei, Denise
    Gyoengyoesi, Mariann
    Pavo, Imre
    Deim, Zoltan
    Szilvassy, Zoltan
    Juhasz, Bela
    Varga, Csaba
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2017, 2017
  • [29] Effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary arterial hypertension in rats
    Tanida, Izumi
    Nisida, Masahiro
    Hasegawa, Youichi
    Inaji, Haruka
    Ohkita, Mamoru
    Matsumura, Yasuo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 267P - 267P
  • [30] The selective estrogen receptor modulator, raloxifene: Reproductive assessments following preimplantation exposure in mated female rats
    Clarke, DO
    Griffey, KI
    Buelke-Sam, J
    Francis, PC
    REPRODUCTIVE TOXICOLOGY, 1998, 12 (03) : 247 - 259